» Articles » PMID: 3896597

Increased Activation of the Alternative Complement Pathway in Sickle Cell Disease

Overview
Date 1985 Oct 1
PMID 3896597
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Complement proteins play an important role in host defenses against Streptococcus pneumoniae, a major cause of serious infections in sickle cell (SS) disease. Previous studies have suggested abnormalities of the alternative complement pathway in SS disease. We measured activation of the alternative pathway in sera from patients with SS disease utilizing an enzyme immunoassay which detects C3b,P complexes, derivative of the C3b,Bb,P alternative pathway convertase. In all, 89% of SS sera had elevated concentrations of C3b,P complexes, indicative of increased alternative pathway activation. Chronic activation of the alternative pathway may contribute to impaired host defense in SS patients.

Citing Articles

Complement in Sickle Cell Disease: Are We Ready for Prime Time?.

Varelas C, Tampaki A, Sakellari I, Anagnostopoulos A, Gavriilaki E, Vlachaki E J Blood Med. 2021; 12:177-187.

PMID: 33790681 PMC: 8001680. DOI: 10.2147/JBM.S287301.


Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction.

Hendrickson J Ann Blood. 2021; 5.

PMID: 33554044 PMC: 7861514. DOI: 10.21037/aob-2020-scd-01.


Role of complement in alloimmunization and hyperhemolysis.

Chonat S, Mener A, Verkerke H, Stowell S Curr Opin Hematol. 2020; 27(6):406-414.

PMID: 32889827 PMC: 8590199. DOI: 10.1097/MOH.0000000000000610.


Factor H: a novel modulator in sickle cell disease.

El Nemer W, Koehl B Haematologica. 2019; 104(5):857-859.

PMID: 31040228 PMC: 6518884. DOI: 10.3324/haematol.2018.214668.


Inflammation in sickle cell disease.

Conran N, Belcher J Clin Hemorheol Microcirc. 2018; 68(2-3):263-299.

PMID: 29614637 PMC: 6314308. DOI: 10.3233/CH-189012.